Celebrating our growing Business Development team

September 17, 2025 11:00 AM PST

We’re thrilled to welcome Kaytrina Anchelia as a Director of Business Development. With nearly a decade of experience driving significant business growth at OmniaBio, iVexSol, and Akron Bio, she brings deep commercial expertise in the cell and gene therapy space.

Kaytrina will leverage her extensive experience to support developers in advancing their programs, forge strategic partnerships, and deliver exceptional value to our clients.

Her excitement and commitment to empowering our peers are exhilarating: “I believe the TARGATT™ genome engineering platform has the potential to solve some of the industry’s most pressing challenges, and I look forward to helping deliver that value to our partners.”

Welcome to the team, Kaytrina!

About Applied StemCell

Founded in 2008 to provide industry and academic researchers with the ability to leverage the power of gene editing and induced pluripotent stem cells (iPSC), Applied StemCell continues to use our innovative technologies to power the discovery and development of advanced therapeutics. With a focus on genome engineering products and services, our patented technologies ensure a clear IP path to commercialization.

Media Contact

Pia Abola
Director of Marketing
pia.abola@appliedstemcell.com
+1 (408) 457-1312